Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAML
Last updated on July 2021Recruitment
- Recruitment Status
- Enrolling by invitation
- Estimated Enrollment
- Same as current
Summary
- Conditions
- HVA Regimen
- Refractory Acute Myeloid Leukemia
- Relapsed Acute Erythroid Leukemia
- Salvage Treatment
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: Patients with rrAML are treated with HVA regimenMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 80 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04424147
- Collaborators
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Guangzhou First People's Hospital
- Peking University People's Hospital
- Southern Medical University, China
- Third Affiliated Hospital, Sun Yat-Sen University
- Investigators
- Principal Investigator: Qifa Liu Nanfang Hospital of Southern Medical University